InnovAge (OTCMKTS:INNV) Stock Price Up 8.1% - Should You Buy?

Market Beat
2025.11.13 22:23
portai
I'm PortAI, I can summarize articles.

Shares of InnovAge Holding Corp. (OTCMKTS:INNV) rose 8.1% to $5.86 with a significant increase in trading volume. The company provides medical and ancillary services for seniors through its PACE approach. Despite the rise, analysts currently rate InnovAge as a Hold, suggesting other stocks may be better buys.

Shares of InnovAge Holding Corp. (OTCMKTS:INNV - Get Free Report) rose 8.1% during trading on Wednesday . The stock traded as high as $5.89 and last traded at $5.86. Approximately 314,161 shares changed hands during trading, an increase of 468% from the average daily volume of 55,345 shares. The stock had previously closed at $5.42.

InnovAge Price Performance

The stock has a market capitalization of $772.02 million, a PE ratio of -18.35 and a beta of 0.59. The company has a quick ratio of 1.57, a current ratio of 1.57 and a debt-to-equity ratio of 0.25. The stock's 50-day moving average is $4.94 and its 200 day moving average is $4.19.

About InnovAge

(Get Free Report)

InnovAge Holding Corp. manages and provides a range of medical and ancillary services for seniors in need of care and support to live independently in their homes and communities. The company manages its business through Program of All-Inclusive Care for the Elderly (PACE) approach. It also offers in-home care services consisting of skilled, unskilled, and personal care; in-center services, such as primary care, physical therapy, occupational therapy, speech therapy, dental services, mental health and psychiatric services, meals, and activities; transportation to the PACE center and third-party medical appointments; and care management.

Further Reading

  • Five stocks we like better than InnovAge
  • Health Care Stocks Explained: Why You Might Want to Invest
  • C3.ai's Reset: Why New Leadership Could Spark a Turnaround
  • Market Cap Calculator: How to Calculate Market Cap
  • CleanSpark Secures $1.15B, Stock Drops—Here's Why It's an Opportunity
  • Investing in the High PE Growth Stocks
  • Why Bulls Should Want a Bigger Drop in Palantir Stock

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in InnovAge Right Now?

Before you consider InnovAge, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and InnovAge wasn't on the list.

While InnovAge currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Source: Market Beat The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.